This is particularly relevant in cells of the HER2 + subtype, as confirmed by the data reported here and in line with several published RS studies focused on the possible categorization of BC cell lines and in vivo tumor subtypes on the basis of a different biochemical composition. The gene discussed is ERBB2; the disease is breast cancer.